Why the study?
The mechanisms underlying thrombocytopenia and platelet disorders in cardiac surgery and extracorporeal life support remain to be cleared.
This review provides a comprehensive summary of the multifactorial causes of platelet derangements in patients undergoing cardiac surgery and extracorporeal life support.
Answers are grounded in this paper and cite their sources.
Awareness of multifactorial platelet derangements may inform perioperative strategies in cardiac surgery and ECLS; leaves open targeted interventions for prospective study.
Thrombocytopenia and impaired platelet function are known as intrinsic drawbacks of cardiac surgery and extracorporeal life supports (ECLS). A number of different factors influence platelet count and function including the inflammatory response to a cardiopulmonary bypass (CPB) or to ECLS, hemodilution, hypothermia, mechanical damage and preoperative treatment with platelet-inhibiting agents. Moreover, although underestimated, heparin-induced thrombocytopenia is still a hiccup in the perioperative management of cardiac surgical and, above all, ECLS patients. Moreover, recent investigations have highlighted how platelet disorders also affect patients undergoing biological prosthesis implantation. Though many hypotheses have been suggested, the mechanism underlying thrombocytopenia and platelet disorders is still to be cleared. This narrative review aims to offer clinicians a summary of their major causes in the cardiac surgery setting.
No takes yet. Share an insight, caveat, or question.
Squiccimarro et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: